EUVIMEDEUVIMED entdecken
Crossref

High‐Efficiency Screening of Compounds Targeting Postmenopausal Osteoporosis in Cuscutae Semen Based on Affinity Ultrafiltration‐UPLC‐QE‐Orbitrap‐MS Platform

Li Yishan iD, Li Yawen, Liu Wanjie, Yang Kunping, Feng Wei iD, Xu Tian, Gao Xiaochen, Sun Jiaming

Phytochemical Analysis · 2025

DOI: 10.1002/pca.70018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytochemical Analysis, 2025. Verfasst von Li Yishan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, China. Hauptthemen laut MEDLINE: Osteoporosis, Postmenopausal, Cuscuta, Mass Spectrometry, Plant Extracts. Die Arbeit nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, the Administration of Traditional Chinese Medicine of Jilin Province, Hebei Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Postmenopausal osteoporosis, a skeletal disorder induced by estrogen deficiency, is commonly addressed in clinical practice through the use of Cuscutae semen and its compound formulations, owing to their significant therapeutic efficacy.

Objective

This study sought to systematically identify bioactive compounds present in Cuscutae semen that interact with estrogen receptor β (ESR2) using Affinity Ultrafiltration combined with Ultra‐Performance Liquid Chromatography‐Quadrupole‐Orbitrap Mass Spectrometry (UPLC‐QE‐Orbitrap‐MS) to find possible therapy options for PMOP.

Methods

The Cuscutae semen extract was fractionated using a C18 column to obtain fractions based on distinct polarity. Preliminary evaluation of anti‐osteoporotic activity was conducted in MC3T3‐E1 cells by assessing osteoprotegerin (OPG) expression. Affinity Ultrafiltration integrated with UPLC‐QE‐Orbitrap‐MS was utilized to screen for ligands binding to ESR2, followed by molecular docking to validate the interaction mechanisms. The osteogenic effects of the identified compounds were further confirmed through CCK‐8 proliferation assays, OPG quantification, and alkaline phosphatase (ALP) activity analysis.

Results

The fraction of Cuscutae semen extract eluted with 100% methanol exhibited significant anti‐osteoporotic activity. Three flavonoids—Astragalin, Isorhamnetin, and Quercitrin—that interact with ESR2 were successfully identified. In vitro validation demonstrated the efficacy of these compounds.

Conclusion

This study presents a comprehensive strategy that integrates Affinity Ultrafiltration, UPLC‐QE‐Orbitrap‐MS, and bioactivity validation to efficiently identify ESR2‐targeted postmenopausal osteoporosis compounds in Cuscutae Semen. The findings offer both theoretical and empirical foundations for the development of innovative therapeutics for postmenopausal osteoporosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteoporosis, PostmenopausalCuscutaMass SpectrometryPlant ExtractsSemenUltrafiltrationChromatography, High Pressure LiquidMiceAnimalsFemaleMolecular Docking SimulationEstrogen Receptor betaHumansCell LineOsteoprotegerinCell Proliferation

Stichwörter der Autor:innen

ESR2UPLC‐QE‐Orbitrap‐MSaffinity ultrafiltrationcuscutae semen

Substanzen

Plant ExtractsEstrogen Receptor betaOsteoprotegerin

Autor:innen und Institutionen

  • Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, China.
  • School of Pharmaceutical Sciences, Quality Evaluation & Standardization Hebei Province Engineering Research Center of Traditional Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.

ORCID-Profile: Li Yishan, Feng Wei

Förderung

  • National Natural Science Foundation of China
  • the Administration of Traditional Chinese Medicine of Jilin Province
  • Hebei Provincial Natural Science Foundation of China
  • S&T Program of Hebei
  • Administration of Traditional Chinese Medicine of Jilin Province

Zitieren

APA

Yishan, L., Yawen, L., Wanjie, L., Kunping, Y., Wei, F., Tian, X., Xiaochen, G., & Jiaming, S. (2025). High‐Efficiency Screening of Compounds Targeting Postmenopausal Osteoporosis in Cuscutae Semen Based on Affinity Ultrafiltration‐UPLC‐QE‐Orbitrap‐MS Platform. Phytochemical Analysis. https://doi.org/10.1002/pca.70018

Vancouver

Yishan L, Yawen L, Wanjie L, Kunping Y, Wei F, Tian X, et al. High‐Efficiency Screening of Compounds Targeting Postmenopausal Osteoporosis in Cuscutae Semen Based on Affinity Ultrafiltration‐UPLC‐QE‐Orbitrap‐MS Platform. Phytochemical Analysis. 2025. doi:10.1002/pca.70018

BibTeX
@article{Yishan2025,
  author = {Yishan, Li and Yawen, Li and Wanjie, Liu and Kunping, Yang and Wei, Feng and Tian, Xu and Xiaochen, Gao and Jiaming, Sun},
  title = {High‐Efficiency Screening of Compounds Targeting Postmenopausal Osteoporosis in Cuscutae Semen Based on Affinity Ultrafiltration‐UPLC‐QE‐Orbitrap‐MS Platform},
  journal = {Phytochemical Analysis},
  year = {2025},
  doi = {10.1002/pca.70018}
}
Kostenlos starten →